172 related articles for article (PubMed ID: 36939385)
1. DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer.
Miller AL; Perurena N; Gardner A; Hinoue T; Loi P; Laird PW; Cichowski K
Cancer Res; 2023 Jun; 83(11):1800-1814. PubMed ID: 36939385
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells.
Duan Y; Yin X; Lai X; Liu C; Nie W; Li D; Xie Z; Li Z; Meng F
Technol Cancer Res Treat; 2020; 19():1533033819895494. PubMed ID: 32336215
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of DAB2IP in pancreatic cancer with wild-type KRAS.
Duan YF; Li DF; Liu YH; Mei P; Qin YX; Li LF; Lin QX; Li ZJ
Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):204-9. PubMed ID: 23558076
[TBL] [Abstract][Full Text] [Related]
4. DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer.
Feng S; Huang Q; Deng J; Jia W; Gong J; Xie D; Shen J; Liu L
Cancer Lett; 2022 Apr; 532():215588. PubMed ID: 35150809
[TBL] [Abstract][Full Text] [Related]
5. EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells.
Zong X; Wang W; Ozes A; Fang F; Sandusky GE; Nephew KP
Cancer Res; 2020 Oct; 80(20):4371-4385. PubMed ID: 32816909
[TBL] [Abstract][Full Text] [Related]
6. DAB2IP in cancer.
Liu L; Xu C; Hsieh JT; Gong J; Xie D
Oncotarget; 2016 Jan; 7(4):3766-76. PubMed ID: 26658103
[TBL] [Abstract][Full Text] [Related]
7. An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB.
Min J; Zaslavsky A; Fedele G; McLaughlin SK; Reczek EE; De Raedt T; Guney I; Strochlic DE; Macconaill LE; Beroukhim R; Bronson RT; Ryeom S; Hahn WC; Loda M; Cichowski K
Nat Med; 2010 Mar; 16(3):286-94. PubMed ID: 20154697
[TBL] [Abstract][Full Text] [Related]
8. DAB2IP with tumor-inhibiting activities exhibits frameshift mutations in gastrointestinal cancers.
Son HJ; Jo YS; Kim MS; Yoo NJ; Lee SH
Pathol Res Pract; 2018 Dec; 214(12):2075-2080. PubMed ID: 30477644
[TBL] [Abstract][Full Text] [Related]
9. Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer.
Bellazzo A; Di Minin G; Collavin L
Cell Death Differ; 2017 Jan; 24(1):15-25. PubMed ID: 27858941
[TBL] [Abstract][Full Text] [Related]
10. The RASSF1A Tumor Suppressor Binds the RasGAP DAB2IP and Modulates RAS Activation in Lung Cancer.
Harrell Stewart DR; Schmidt ML; Donninger H; Clark GJ
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33348649
[TBL] [Abstract][Full Text] [Related]
11. A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancers.
Šuštić T; van Wageningen S; Bosdriesz E; Reid RJD; Dittmar J; Lieftink C; Beijersbergen RL; Wessels LFA; Rothstein R; Bernards R
Genome Med; 2018 Nov; 10(1):90. PubMed ID: 30482246
[TBL] [Abstract][Full Text] [Related]
12. Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers.
Olsen SN; Wronski A; Castaño Z; Dake B; Malone C; De Raedt T; Enos M; DeRose YS; Zhou W; Guerra S; Loda M; Welm A; Partridge AH; McAllister SS; Kuperwasser C; Cichowski K
Cancer Discov; 2017 Feb; 7(2):202-217. PubMed ID: 27974415
[TBL] [Abstract][Full Text] [Related]
13. DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation.
Zhou Y; Yang Z; Zhang H; Li H; Zhang M; Wang H; Zhang M; Qiu P; Zhang R; Liu J
Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166353. PubMed ID: 35063646
[TBL] [Abstract][Full Text] [Related]
14. Smurf1 regulation of DAB2IP controls cell proliferation and migration.
Li X; Dai X; Wan L; Inuzuka H; Sun L; North BJ
Oncotarget; 2016 May; 7(18):26057-69. PubMed ID: 27036023
[TBL] [Abstract][Full Text] [Related]
15. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Wang B; Gu Q; Li J
Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
[TBL] [Abstract][Full Text] [Related]
16. DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor.
Yu L; Tumati V; Tseng SF; Hsu FM; Kim DN; Hong D; Hsieh JT; Jacobs C; Kapur P; Saha D
Neoplasia; 2012 Dec; 14(12):1203-12. PubMed ID: 23308052
[TBL] [Abstract][Full Text] [Related]
17. Negative regulation of DAB2IP by Akt and SCFFbw7 pathways.
Dai X; North BJ; Inuzuka H
Oncotarget; 2014 May; 5(10):3307-15. PubMed ID: 24912918
[TBL] [Abstract][Full Text] [Related]
18. miR-92b promotes gastric cancer growth by activating the DAB2IP-mediated PI3K/AKT signalling pathway.
Ni QF; Zhang Y; Yu JW; Hua RH; Wang QH; Zhu JW
Cell Prolif; 2020 Jan; 53(1):e12630. PubMed ID: 31713929
[TBL] [Abstract][Full Text] [Related]
19. The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.
Tsai YS; Lai CL; Lai CH; Chang KH; Wu K; Tseng SF; Fazli L; Gleave M; Xiao G; Gandee L; Sharifi N; Moro L; Tzai TS; Hsieh JT
Oncotarget; 2014 Aug; 5(15):6425-36. PubMed ID: 25115390
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer.
Calvisi DF; Ladu S; Conner EA; Seo D; Hsieh JT; Factor VM; Thorgeirsson SS
J Hepatol; 2011 Feb; 54(2):311-9. PubMed ID: 21067840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
